FDA Clears 3D-Printed Titanium Cervical Implant From Elevation Spine

The FDA has granted 510(k) clearance to Elevation Spine for its Saber-C AVIA cervical fixation system, making a 3D-printed titanium spine implant immediately available to surgeons across the United States. The device is built around a porous titanium interbody with a lattice structure designed to mimic real trabecular bone.

What the clearance covers

Saber-C AVIA is a zero-profile anterior cervical discectomy and fusion system. It combines a plate, interbody spacer, and fixation into a single low-profile construct that sits flush with the vertebral body. The 3D-printed titanium interbody has a 55% porosity lattice architecture intended to support bone ingrowth, and the system offers both spike and screw fixation options. Surgeons can choose between 6 degrees of lordosis and 12 degrees of hyperlordotic angulation depending on the patient's anatomy.

Why the lattice matters

Conventional cervical interbody spacers are often machined from solid titanium or PEEK. Those materials are stable, but they do not invite bone to grow into the implant. The porous lattice in Saber-C AVIA is meant to change that. Preclinical data associated the structure with bone ingrowth, which could translate to stronger long-term fusion rates. The large central graft window gives surgeons room to pack autograft or allograft material alongside the implant.

A smaller company moving fast

Elevation Spine is based in Monterey, California, and stays lean by design. CEO Charlie Gilbride said the company keeps close to its surgeon network and moves quickly on feedback. The Saber-C AVIA system reflects that approach: refined spike instruments for more precise delivery, a new low-profile screw inserter, and a single tray that carries both fixation options for every case. Existing Saber-C users will recognize the platform; the AVIA update is an evolution, not a redesign.

Medical 3D printing hits a milestone

3D-printed spinal implants are not new, but FDA clearances for specific systems still carry weight. A 510(k) pathway means the agency found the device substantially equivalent to a predicate already on the market, which is a pragmatic route for incremental innovation. The clearance does not require new clinical trials, but it does confirm that the manufacturing controls, materials, and design meet the FDA's expectations for safety. For Elevation Spine, the win opens the door to selling the system immediately without further regulatory delay.

What to watch next

The system is available now. The real test will be adoption speed and surgeon preference. If the porous lattice delivers on its bone-ingrowth promise, it could push more spinal systems toward 3D-printed titanium as a default rather than a premium option. For now, Elevation Spine has a cleared product, a growing surgeon community, and a small enough footprint to iterate fast if the market asks for changes.